Feb Vertex Update - Kalydeco receives FDA approval for 8 gating mutations

I've just summarised the Feb 25 Vertex investor conference, includes info about Kalydeco, VX809, VX661 and second generation correctors:

http://sixtyfiverosesblog.wordpress....vertex-update/

Also, last week it was announced that Kalydeco received FDA approval for eight gating mutations: G178R, S549N, S549R, G551S, G1244E, S1251N, S1255P and G1349D.

http://investors.vrtx.com/releasedet...leaseID=827435

Source: Cystic Fibrosis CFTR Modulation and Gene Therapy Forum - February 27, 2014 Category: Respiratory Medicine Authors: GenH Tags: CFTR Modulation and Gene Therapy Talk Source Type: forums